ClinicalTrials.Veeva

Menu

Prevalence and Characteristics of Patients With Bronchiectasis Comorbid Nontuberculous Mycobacteria

B

Bin Cao

Status

Unknown

Conditions

Non-tuberculous Mycobacterial
Bronchiectasis

Study type

Observational

Funder types

Other

Identifiers

NCT03594032
2018-62-K46

Details and patient eligibility

About

The purpose of this study is to Understand the prevalence of non-tuberculous mycobacterial(NTM) infections in the middle-aged and old women patients with bronchiectasis in Mainland China, and explore the characteristics of patients with bronchiectasis comorbid NTM.

Full description

The development of bronchiectasis is closely related to chronic infection of pathogenic microorganisms .Bronchiectasis and nontuberculous mycobacterial (NTM) infections are inextricably linked Pathophysiologically. But the incidence rate and characteristics of NTM infections among patients with bronchiectasis remains unclear in mainland China.

In this study, we will collect data of participants about demographic ,co-morbidities ,spirometry, mMRC score ,exacerbation history, QOL-B questionnaire, aetiology, spirometry , HRCT(or CT) scan ,results of microbiology samples and treatments, collect three consecutive sputum(or induced sputum) samples to smear, bacteria culture, acid-fast stain, mycobacterium cultivation and identification, drug susceptibility testing of nontuberculous mycobacteria.To estimate the prevalance of non-tuberculous mycobacterial(NTM) infections in Middle-aged and old women patients with bronchiectasis in northern China. To analyze clinical manifestations and microbiological characteristics of patients with bronchiectasis comorbid NTM infections By 16SRNA and gene sequencing.

In addition, A cross-sectional investigation about lung function and clinical data will be done among patients who have confirmed bronchiectasis with NTM from February 2017 to December 2020.

Enrollment

216 estimated patients

Sex

Female

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Middle-aged and old women who are > or = 50 years of age
  2. Patients meet the criteria of bronchiectasis

Exclusion criteria

  1. Cystic fibrosis
  2. After organ transplantation
  3. Activity tumor (malignant solid tumor and blood system tumor)
  4. Pulmonary interstitial fibrosis with bronchus dilation
  5. Allergic bronchopulmonary aspergillosis
  6. Diffuse panbronchiolitis
  7. Patients refused to sign the informed consent
  8. Patients unable to return sputum specimens

Trial contacts and locations

1

Loading...

Central trial contact

Hongjun Yin, MD; Ben Cao, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems